ID19099A - ORAL COMPOSITION - Google Patents

ORAL COMPOSITION

Info

Publication number
ID19099A
ID19099A IDP971991A ID971991A ID19099A ID 19099 A ID19099 A ID 19099A ID P971991 A IDP971991 A ID P971991A ID 971991 A ID971991 A ID 971991A ID 19099 A ID19099 A ID 19099A
Authority
ID
Indonesia
Prior art keywords
oral composition
oral
composition
Prior art date
Application number
IDP971991A
Other languages
Indonesian (id)
Inventor
Robert Ernest Singer Jr
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ID19099A publication Critical patent/ID19099A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
IDP971991A 1996-06-12 1997-06-11 ORAL COMPOSITION ID19099A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66238996A 1996-06-12 1996-06-12

Publications (1)

Publication Number Publication Date
ID19099A true ID19099A (en) 1998-06-11

Family

ID=24657514

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971991A ID19099A (en) 1996-06-12 1997-06-11 ORAL COMPOSITION

Country Status (8)

Country Link
EP (1) EP0954294A1 (en)
JP (1) JPH11513035A (en)
CN (1) CN1221338A (en)
AU (1) AU3306997A (en)
BR (1) BR9709792A (en)
CA (1) CA2257990A1 (en)
ID (1) ID19099A (en)
WO (1) WO1997047292A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
WO2001074780A1 (en) * 2000-03-21 2001-10-11 Astion Development Aps Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
CN1536989A (en) 2000-06-30 2004-10-13 Oral compositions comprising host-respones modulating agent for promoting whole body health
JP2004517038A (en) * 2000-06-30 2004-06-10 ザ、プロクター、エンド、ギャンブル、カンパニー Overall health promotion
JP2003321366A (en) * 2002-04-30 2003-11-11 Ucb Japan Kk Prophylactic or treating agent for inflammatory enteropathy
ITMI20031640A1 (en) * 2003-08-08 2005-02-09 Mipharm S P A BASE FOR BIOADHESIVE GEL.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
JPH06506198A (en) * 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー Novel salt/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis

Also Published As

Publication number Publication date
JPH11513035A (en) 1999-11-09
BR9709792A (en) 1999-08-10
WO1997047292A1 (en) 1997-12-18
AU3306997A (en) 1998-01-07
EP0954294A1 (en) 1999-11-10
CA2257990A1 (en) 1997-12-18
CN1221338A (en) 1999-06-30

Similar Documents

Publication Publication Date Title
ID20233A (en) ORAL COMPOSITION
ID19097A (en) ORAL COMPOSITIONS
BR9508844A (en) Oral composition
ID26720A (en) ORAL COMPOSITION
DE69718508D1 (en) ANTITRASPIRANT COMPOSITION
NO985460D0 (en) size composition
BR9506536A (en) Oral composition
FI963421A0 (en) Oral auxiliary compositions
DE69526966D1 (en) SKIN-STRENGTHING COMETIC COMPOSITION
TR199501447A2 (en) Oral compositions.
DE69721231D1 (en) ANISOTROP LEADING COMPOSITION
ID25508A (en) DEMATOLOGICAL COMPOSITION
ID18359A (en) MICROCAPSUL COMPOSITION
DE69623255D1 (en) Dental cement composition
FI954773A0 (en) Anti-hypertriglyceridemia composition
ID17860A (en) VACCINE COMPOSITION
ATE293672T1 (en) COLOR-FRIENDLY COMPOSITIONS
DE69719442D1 (en) Frisierschaum compositions
BR9510467A (en) Oral compositions
DK1023035T3 (en) The oral composition
ID20466A (en) ORAL COMPOSITION
ID17561A (en) COMPOSITION FOR USE OUTSIDE
ID23250A (en) PAROXSETIN COMPOSITION
ID21906A (en) ADESIVE COMPOSITION
ID19589A (en) COMPOSITION